CAMP4 Therapeutics Corp

The current institutional shareholding score of CAMP4 Therapeutics Corp is 7.00, ranking 80 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 82.01%, representing a quarter-over-quarter increase of 237.71%. The largest institutional shareholder is Steven Cohen, holding a total of 18.15K shares, representing 0.03% of shares outstanding, with 10.18% decrease in holdings.